Functional neuroimaging data from adults have, in general, revealed frontocerebellar dysfunction associated with acute and chronic marijuana (MJ) use. The goal of this study was to characterize cerebellar volume in adolescent chronic MJ users following 1 month of monitored abstinence. Participants were MJ users (n = 16) and controls (n = 16) aged 16-18 years. Extensive exclusionary criteria included history of psychiatric or neurologic disorders. Drug use history, neuropsychological data, and structural brain scans were collected after 28 days of monitored abstinence. Trained research staff defined cerebellar volumes (including three cerebellar vermis lobes and both cerebellar hemispheres) on high-resolution T1-weighted magnetic resonance images. Adolescent MJ users demonstrated significantly larger inferior posterior (lobules VIII-X) vermis volume than controls, above and beyond effects of lifetime alcohol and other drug use, gender, and intracranial volume. Larger vermis volumes were associated with poorer executive functioning. Following 1 month of abstinence, adolescent MJ users had significantly larger posterior cerebellar vermis volumes than nonusing controls. These greater volumes are suggested to be pathological based on linkage to poorer executive functioning. Longitudinal studies are needed to examine typical cerebellar development during adolescence and the influence of marijuana use.
Introduction
Marijuana (MJ) (active ingredient delta-9-tetrahydrocannabinol or THC) continues to be the most popular illicit drug used among teens, with almost half of 12th graders having tried MJ (Johnston et al., 2008) . Given the high prevalence of MJ use during adolescence, a time of continued neurodevelopment (e.g., Giedd et al., 1996; Gogtay et al., 2004; Lenroot and Giedd, 2006; Nagel et al., 2006; Pfefferbaum et al., 1994; Sowell et al., 2004) , the influence of chronic use of MJ on brain morphometry among teens is of great interest.
Animal and human studies have suggested that the cerebellum may be vulnerable to the effects of chronic MJ exposure (Chang and Chronicle, 2007; Loeber and Yurgelun-Todd, 1999; Quickfall and Crockford, 2006) . THC affects the brain via the cannabinoid receptors (CB 1 ). Animal studies have shown high densities of the CB 1 receptor in many brain regions, including the cerebellum, frontal lobes, basal ganglia, limbic forebrain, hypothalamus, and hippocampus (Iversen, 2003; Herkenham et al., 1990 Herkenham et al., , 1991 Herkenham, 1992; Mackie, 2008; Yoshida et al., 2006) , although non-human animals have greater cerebellar CB 1 density than humans (McPartland et al., 2007; Herkenham et al., 1990) . Endogenous cannabinoids have inhibitory effects on both excitatory and inhibitory neurotransmitter release, and play an important role in control of neural circuits, such as in the cerebellum (Childers and Breivogel, 1998; Ghozland et al., 2002; Harkany et al., 2008a,b; Iversen, 2003; Pazos et al., 2005; Pistis et al., 2004; Lau and Schloss, 2008; Suárez et al., 2008) . More specifically, animal research has suggested a prominent role of the endogenous cannabinoid system as a retrograde messenger in Purkinje cell synapses, the principal cortical neuron in the cerebellum (Suárez et al., 2008; Yamasaki et al., 2006) .
The cerebellum plays a pivotal role in balance and psychomotor speed, as well as language generation, time estimation, rhythm production, inhibition, attention, and associative memory (Allen and Courchesne, 2003; Courchesne et al., 1994; Ivry et al., 1988; Leiner et al., 1993; Luna and Sweeney, 2001; Mathew et al., 1998; Timmann et al., 2002; Schmahmann and Sherman, 1998) . Consistent with this, exposure to exogenous cannabinoids in animals results in motor abnormalities (Adams and Martin, 1996; Iversen, 2003; Rodríguez de Fonseca et al., 1998; Patel and Hillard, 2001 ) that are at least partially mediated by CB 1 receptor changes in the cerebellum (Casu et al., 2005; Dar, 2000; DeSanty and Dar, 2001 ).
These animal findings are supported by human neuroimaging studies using functional magnetic resonance imaging (fMRI), positron emission tomography (PET) or single photon emission computed 
